9 Meters      

Still experiencing symptoms on a gluten-free diet? The CeDLara Study is currently enrolling qualified patients into their phase 3 study to assess a potential therapy for celiac disease. This study is being conducted to determine if the drug reduces symptoms of celiace disease in patients who are on a gluten-free diet. You may qualify to participate in this study if you:

  • Are 18 years old or older
  • Are biopsy diagnosed with celiac disease
  • Are actively experiencing symptoms related to celiac disease such as abdominal pain, abdominal cramping, bloating or gas
  • Have been on a gluten-free diet for at least 6 months

CeDLara study sites are following local COVID-19 safety standards and guidelines to keep participants safe.

For more information or eligibility criteria, call our Research Hotline number at 612-870-5599, OR input the following information and we will follow up with you to discuss your interest:

ATTENTION: This form is for information only and does not guarantee participation in any study. This form is also not meant for transmitting medical, prescription or appointment information or to initiate direct communications with our health care providers. Those inquiries should be sent through the Patient Portal or you can contact us at (612) 871-1145. Web form submissions are monitored Monday through Friday during regular business hours. In the event of a medical emergency, please dial 911.